The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Nurnberg, H. G.
* Articles by Smith, M. D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Nurnberg, H. G.
* Articles by Smith, M. D.
Related Collections
* Depression
* Sexual Disorders
* Other Somatic Therapy
Am J Psychiatry 158:1926-1928, November 2001
© 2001 American Psychiatric Association


Brief Report

Efficacy of Sildenafil Citrate for the Treatment of Erectile Dysfunction in Men Taking Serotonin Reuptake Inhibitors

H. George Nurnberg, M.D., Alan Gelenberg, M.D., Timothy B. Hargreave, M.D., Wilma M. Harrison, M.D., Richard L. Siegel, M.D., and Michael D. Smith, Ph.D.

OBJECTIVE: This study was an evaluation of whether sildenafil citrate is effective for the treatment of erectile dysfunction in men taking concomitant serotonin-reuptake-inhibiting antidepressants. METHOD: A retrospective subanalysis of combined data from 10 phase II/III double-blind, placebo-controlled, fixed- and flexible-dose trials (12–26 weeks) identified a group of men with erectile dysfunction receiving 5 to 200 mg/day of sildenafil (N=65) or placebo (N=33) and concomitant serotonin-reuptake-inhibiting antidepressants. Efficacy was measured by responses to questions from the International Index of Erectile Function on ability to achieve erection, ability to maintain erection, ejaculation frequency, orgasm frequency, and sexual desire. RESULTS: Patients with erectile dysfunction receiving sildenafil and concomitant serotonergic antidepressants had significantly greater improvements in ability to achieve and maintain an erection, frequency of ejaculation, and orgasm frequency than did patients receiving placebo, without increased sexual desire. CONCLUSIONS: Sildenafil significantly improved erectile dysfunction in patients taking concomitant serotonergic antidepressants.




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
D. Baldwin, J. Hutchison, K. Donaldson, B. Shaw, and A. Smithers
Selective serotonin re-uptake inhibitor treatment-emergent sexual dysfunction: randomized double-blind placebo-controlled parallel-group fixed-dose study of a potential adjuvant compound, VML-670
J Psychopharmacol, January 1, 2008; 22(1): 55 - 63.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
R. Rosen, R. Shabsigh, M. Berber, P. Assalian, M. Menza, L. Rodriguez-Vela, R. Porto, K. Bangerter, M. Seger, F. Montorsi, et al.
Efficacy and Tolerability of Vardenafil in Men With Mild Depression and Erectile Dysfunction: The Depression-Related Improvement With Vardenafil for Erectile Response Study
Am J Psychiatry, January 1, 2006; 163(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, October 6, 2003; 327(7418): E94 - 94.
[Full Text] [PDF]


Home page
JAMAHome page
H. G. Nurnberg, P. L. Hensley, A. J. Gelenberg, M. Fava, J. Lauriello, and S. Paine
Treatment of Antidepressant-Associated Sexual Dysfunction With Sildenafil: A Randomized Controlled Trial
JAMA, January 1, 2003; 289(1): 56 - 64.
[Abstract] [Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Does Sildenafil Help Antidepressant-Induced Erectile Dysfunction? Does It Also Raise Mood?
Journal Watch Psychiatry, November 15, 2001; 2001(1115): 1 - 1.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org